Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | CuttingEdgeInfo Reports | Managing Clinical Investigator Compensation (PH126)

Managing Clinical Investigator Compensation (PH126)

Improve cost-effectiveness of investigator compensation - and ensure compliance.

Establishing transparent and defensible compensation processes for clinical investigators not only saves money - it is absolutely essential in today's restrictive pharma landscape. Regulatory groups, legislative bodies and consumer advocacy groups are applying relentless pressure on commercial relationships with physicians, altering and often limiting industry practices. Now the ripple effect is hitting clinical operations. Some investigations in the area have garnered public attention, with more bound to follow.

Cutting Edge Information projects that within five years the same regulatory scrutiny currently on the commercial side will expand to the clinical side. Companies that do not recognize this inevitable reality and formalize their FMV processes today put themselves at great risk for compromised trial results, an audit, financial damage and regulatory scrutiny. Diligence and constant monitoring will go a long way to preventing careless errors and courting potentially dangerous consequences.

Managing Clinical Investigator Compensation gives your company what it needs to be proactive and prepare for change while avoiding common pitfalls. CEI surveyed more than 50 companies of all types and sizes, across 13 different therapeutic areas, for the most up-to-date compensation rates for clinical investigators. For the most comprehensive analysis, CEI compiled and analyzed data from companies' clinical operations as well as primary investigators.

Use the data benchmarks to:

* Control costs

* Establish current, market based payments to investigators

* Develop regulation-proof calculation and documentation methods

* Stay current on the latest FMV regulation concerns and trends

Companies Included in Report

The surveyed companies provided primary information either in the form of survey data or a telephone interview. Cutting Edge Information's analysts use secondary data to supplement the information provided by study participants. Responding companies include five top 20 and 10 Top 50 pharmaceutical companies, as well as biotechnology companies, medical device firms and third-party providers.

Therapeutic Areas Included in Report

* Autoimmune

* Cardiology and Thrombosis

* CNS/Psychology

* Dermatology

* Endocrinology

* Gastroenterology

* Hematology

* Infectious Diseases

* Medical Devices

* Musculoskeletal

* Oncology

* Respiratory

* Women's Health

Published 2009

104 Pages

500+ Metrics

50+ Charts and Diagrams

Table of Contents
Price: $7,695.00 / €5,143.34

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions